Optiscan unveils real-time digital pathology device

Australian medtech company Optiscan Imaging has unveiled its latest innovation, a microscopic medical imaging device designed to transform pathology by providing real-time digital insights at the point-of-care with a tissue sample.

Designed and manufactured in Melbourne in collaboration with industrial design firm Design + Industry, InForm represents a major step forward in digital pathology.

Optiscan CEO and Managing Director, Dr Camile Farah, emphasised the significance of this advancement, stating, “The reveal of our revolutionary InForm device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. It has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis.”

Historically, tissue pathology has lagged behind radiology and diagnostic imaging in adopting end-to-end digital workflows. Despite its critical role in modern medicine, pathology has remained reliant on slow, analogue processes that require multiple time-intensive procedures, resource-heavy slide preparation, and delayed result interpretation.

Dr Farah highlighted the company’s commitment to transforming this landscape, stating, “Adapting our patented technology for the pathology market signifies a revolutionary leap towards this goal. With InForm, Optiscan is proud to be taking a leading position in this space, as we aim to transform pathology practice with real-time point-of-care digital imaging.”

Optiscan’s “digital first” approach is designed to improve workflow efficiency and diagnostic accuracy compared to traditional glass slide digitisation, which adds complexity and cost to an already time-consuming process.

“We now look forward to updating the market on further InForm device-specific developments over coming months, including its planned integration with Optiscan’s cloud-based telepathology streaming platform,” Dr Farah added.

Engineered for seamless usability across all anatomical pathology applications, InForm offers a spatial resolution of 0.55, delivering up to 1000x real magnification at point-of-care – a significant leap from the conventional 40-100x magnification of traditional light microscopes. The device produces instant digital images and eliminates the need for consumables beyond the topical dye preferred by the pathologist.

InForm is also DICOM-compliant and PACS-enabled, ensuring integration with hospital and laboratory archiving systems akin to radiology platforms like CT and MRI. This capability is a crucial step in bridging pathology with broader healthcare infrastructure, an area that has long trailed diagnostic radiology in digital adoption.

Additionally, Optiscan plans to integrate InForm with its cloud-based telepathology streaming platform, enabling remote, real-time consultation from anywhere in the world. This platform is expected to be unveiled in mid-2025.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.